Madison Wis . - GenTel BioSurfaces Inc. has launched PATHT HTS a new platform for high-throughput quantitative immunoassays. PATH HTS was introduced last week at the microarray industry's annual conference Chips To Hits in Boston. Our customers have been very pleased with the performance of PATH protein microarray slides said Robert Negm vice president of business developmen
Madison, Wis. - GenTel BioSurfaces, Inc. has launched PATHT HTS, a new platform for high-throughput quantitative immunoassays. PATH HTS was introduced last week at the microarray industry's annual conference, Chips To Hits in Boston.
"Our customers have been very pleased with the performance of PATH protein microarray slides," said Robert Negm, vice president of business developmen......
Full article >>>'"/>Source:wistechnology.com By WTN News 09/20/05
Page: 1 Related biology technology :1.
GenTel acquires GlaxoSmithKline chip platform2.
New angel capital centered on GenTel agreement with big pharma3.
GenTel licenses next generation cancer research4.
GenTel to distribute cancer research tool5.
GenTel gets federal grant to develop allergy test6.
Madisons GenTel partners with Taiwan firm7.
Fisher Biosciences contracts with Madison-based GenTel BioSurfaces8.
GenTel will sell Dutch firms biomolecule labeling technology9.
Bone Care, GenTel, MyWeather10.
GenTel receives $250,000 state loan11.
GenTel claims $900,000 in federal grants this year for biochip research